John L. Magnani - SVP of Research, CSO at CRESCENT BIOPHARMA, INC.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by John L. Magnani since 03 Jul 2025

Reported holdings for John L. Magnani in CRESCENT BIOPHARMA, INC.

Form 4 holding SVP of Research, CSO

GLYCOMIMETICS INC

Security class
Common Stock
Shares / value
366,078
Estimated value
$863,944
Report date
11 Nov 2022
Price
$2.36
Ownership
Direct
Form 4 holding SVP of Research, CSO

GLYCOMIMETICS INC

Security class
Common Stock
Shares / value
4,845
Estimated value
$11,434
Report date
11 Nov 2022
Price
$2.36
Ownership
By GlycoTech Corporation

Transaction history for John L. Magnani in CRESCENT BIOPHARMA, INC.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .